Item no. |
NKM-ATGP0404-500ug |
Manufacturer |
NKMAX
|
Amount |
500 ug |
Quantity options |
100 ug
20 ug
500 ug
|
Category |
|
Type |
Proteins Recombinant |
Format |
Liquid |
Applications |
SDS-PAGE |
Specific against |
Human (Homo sapiens) |
Host |
E.coli |
Conjugate/Tag |
Untagged |
Purity |
> 95% by SDS-PAGE |
Sequence |
MSILKIHARE IFDSRGNPTV EVDLFTSKGL FRAAVPSGAS TGIYEALELR DNDKTRYMGK GVSKAVEHIN KTIAPALVSK KLNVTEQEKI DKLMIEMDGT ENKSKFGANA ILGVSLAVCK AGAVEKGVPL YRHIADLAGN SEVILPVPAF NVINGGSHAG NKLAMQEFMI LPVGAANFRE AMRIGAEVYH NLKNVIKEKY GKDATNVGDE GGFAPNILEN KEGLELLKTA IG |
Citations |
Das R., et al. (2009) Blood. 113(22):5371-2. ueno NT., et al. (2008) Cancer Res. 68(22):9302-10.
Chen X, et al. Interaction between granulin A and enolase 1 attenuates the migration and invasion of human hepatoma cells. (Oncotarget. 2017){https://pubmed.ncbi.nlm.nih.gov/28415822/} Hashimoto Y, et al. Comparison of clinical characteristics in patients with Vogt-Koyanagi-Harada disease with and without anti-retinal antibodies. (Graefes Arch Clin Exp Ophthalmol. 2019){https://pubmed.ncbi.nlm.nih.gov/31065846/} Hirakata T, et al. Acute unilateral inner retinal dysfunction with photophobia: importance of electrodiagnosis. (Jpn J Ophthalmol. 2020){https://pubmed.ncbi.nlm.nih.gov/33180210/} Hashimoto Y, et al. Comparison of clinical characteristics in patients with acute zonal occult outer retinopathy according to anti-retinal antibody status. (Graefes Arch Clin Exp Ophthalmol. 2021){https://pubmed.ncbi.nlm.nih.gov/33876277/} Inoue Y, et al. α-Enolase reduces cerebrovascular Aβ deposits by protecting Aβ amyloid formation. (Cell Mol Life Sci. 2022){https://pubmed.ncbi.nlm.nih.gov/35916996/} |
NCBI |
NP_001419.1 |
ECLASS 10.1 |
32160409 |
ECLASS 11.0 |
32160409 |
UNSPSC |
12352202 |
Alias |
Alpha-enolase, 2-phospho-D-glycerate hydro-lyase, C-myc promoter-binding protein, Enolase 1, MBP-1, MPB-1, Non-neural enolase, NNE, Phosphopyruvate hydratase, PPH, Plasminogen-binding protein, ENO1L1, MBPB1, MPB1, ENO1-IT1, ENO1 intronic transcript 1 |
Similar products |
ENO1, MBP1, EC 4.2.1.11, NNE, ENO1L1, MBP-1, MPB1, PPH, MYC promoter-binding protein 1, Non-Neuronal Enolase, Enolase-1, Alpha enolase, Enolase 1, MBP 1, MBPB1, MPB-1, Phosphopyruvate hydratase, Tau-crystallin, C myc promoter binding protein, Plasminogen binding protein, 2 phospho D glycerate hydro lyase, Enolase 1 (alpha), Enolase 1 (alpha) like 1, MPB 1, MYC promoter binding protein 1, Tau crystallin, Non-Neuronal Enolase (NNE), Non Neuronal Enolase, MBPB-1, MBPB 1, Enolase1, EC4.2.1.11, ATGP0404-10ug, ATGP0404-20ug, ATGP0404-50ug, ATGP0404-100ug, ATGP0404-250ug, ATGP0404-500ug, ATGP0404-1mg, ATGP0404-010, ATGP0404-020, ATGP0404-050, ATGP0404-100, ATGP0404-250, ATGP0404-500, ATGP0404-01M |
Available |
|
Manufacturer - Type |
Recombinant Protein |
Manufacturer - Applications |
SDS-PAGE, Enzyme Activity |
Storage Conditions |
Can be stored at +2C to +8C for 1 week. For long term storage, aliquot and store at -20C to -80C. Avoid repeated freezing and thawing cycles. |
Molecular Weight |
47.1 kDa (434aa) confirmed by MALDI-TOF |
Description |
Alpha-enolase, also known as Enolase 1, is one of three enolase isoenzymes and a glycolytic enzyme expressed in most tissues. This protein plays a key role in anaerobic metabolism under hypoxic conditions and may act as a cell surface plasminogen receptor during tissue invasion. Abnormal expression of alpha-enolase is associated with tumor progression in some cases of breast and lung cancer. It also has been identified as an autoantigen associated with Hashimoto's encephalopathy and severe asthma. Recombinant human alpha-enolase was expressed in E. coli and purified by using conventional chromatography. |
Concentration |
1mg/ml (determined by Bradford assay) |
Formulation |
Liquid in. 20mM Tris-HCl buffer (pH 7.5) containing 1mM MgSO4, 10% glycerol |
Antigen Species |
Human |
Gene Category |
Metabolism |
Domain |
1-434aa |
Endotoxin |
< 1 EU per 1ug of protein (determined by LAL method) |
Bioactivity Comment Only |
Specific activity is > 20, 000pmol/min/ug, and was obtained by measuring the decrease of NAD in absorbance at 340nm resulting from NADH at pH 6.5 at 37C. |
Species of Protein |
Human |
Manufacturer - Search Terms |
Tau-crystallin, Tau crystallin, PPH, Plasminogen binding protein, Phosphopyruvate hydratase, Non-Neuronal Enolase (NNE), Non-Neuronal Enolase, Non Neuronal Enolase, NNE, MYC promoter-binding protein 1, MYC promoter binding protein 1, MPB-1, MPB1, MPB 1, MBPB-1, MBPB1, MBPB 1, MBP-1, MBP1, MBP 1, Enolase-1, Enolase1, Enolase 1 (alpha) like 1, Enolase 1 (alpha), Enolase 1, ENO1L1, ENO1, EC4.2.1.11, EC 4.2.1.11, C myc promoter binding protein, Alpha enolase, 2 phospho D glycerate hydro lyase, ATGP0404-10ug, ATGP0404-20ug, ATGP0404-50ug, ATGP0404-100ug, ATGP0404-250ug, ATGP0404-500ug, ATGP0404-1mg, ATGP0404-010, ATGP0404-020, ATGP0404-050, ATGP0404-100, ATGP0404-250, ATGP0404-500, ATGP0404-01M |
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.